Proof Daylight Saving Time Is Dumb, Dangerous, and
Proof Daylight Saving Time Is Dumb, Dangerous, and Costly
The case against changing the clocks keeps getting stronger.
If you hate daylight saving time and all the confusion and sleep deprivation it brings, you now have solid data on your side. A wave of new research is bolstering arguments against changing our clocks twice a year.
The case for daylight saving time has been shaky for a while. The biannual time change was originally implemented to save energy. Yet dozens of studies around the world have found that changing the clocks has either minuscule or non-existent effects on energy use. After Indiana finally implemented daylight saving, something that didn't happen until 2006, residents actually used more electricity.
Daylight saving time isn’t just a benign relic of the 1970s energy crisis. The latest research suggests the time change can be harmful to our health and cost us money. The effects are most disruptive in the spring and fall, right after the time changes occur. Clocks in the U.S. will spring forward this year on Sunday, March 12. Most of Europe moves to daylight saving time two weeks later.
The suffering of the spring time change begins with the loss of an hour of sleep. That might not seem like a big deal, but researchers have found it can be dangerous to mess with sleep schedules. Car accidents, strokes, and heart attacks spike in the days after the March time change. It turns out that judges, sleep deprived by daylight saving, impose harsher sentences.
“Even mild changes to sleep patterns can affect human capital in significant ways,” two Cornell University researchers, Lawrence Jin and Nicolas Ziebarth, wrote (PDF) last year.
Some of the last defenders of daylight saving time have been a cluster of business groups who assume the change helps stimulate consumer spending. That’s not true either, according to recent analysis of 380 million bank and credit-card transactions by the JPMorgan Chase Institute
The study compared Los Angeles with Phoenix in the 30 days after the March and November time changes. Arizona is a natural test case since it's one of the two states, along with Hawaii, that doesn’t do daylight saving. In the spring, according to the consumer transaction data, the additional hour of evening daylight in Los Angeles managed to slightly boost card spending per person, compared with that in Phoenix, although by less than 1 percent. That spending uptick is swamped by the negative impact of the November time change, which sees the darkened population of Los Angeles spend 3.5 percent less at local retailer
After the autumn time change, shoppers made far fewer trips to the store, especially during the week. Grocery stores, discount stores, and other retailers bore the brunt, while restaurants and service businesses were mostly unaffected.
In other words, daylight turns out to be a surprisingly large factor in how often workers stop at stores on their way home from their jobs in the evening. “At the end of the day, it’s either dark or light, and [people are] going to make an impulse decision at that point,” Diana Farrell, president and chief executive of the JPMorgan Chase Institute.
One possible explanation for the sharp spending decline, Farrell said, is that the extra hour of darkness could push more people to shop online rather than in-person. The study looked only at transactions via local retailers.
Daylight saving time may threaten our health, hurt local retailers, and otherwise disrupt our lives. But can anything be done about it?
As Hawaii and Arizona show, the U.S. government gives states a choice as to whether to adopt daylight saving time. But states aren't currently allowed to switch to daylight saving time year-round. Last year, 19 bills were pending in state legislatures around the U.S. to end the biannual time change, according to the National Conference of State Legislatures. None passed.
Daylight saving is “an example of how sticky policy can be,” Farrell said.
Since the beginning of the year, state legislators have introduced an additional 20 bills on the topic, according to the NCSL. Eleven bills, including proposals in Texas and California, would put states permanently on standard time; nine of the bills aim to make daylight saving time permanent, many of them by urging lawmakers in Washington to change the rules.
That looks unlikely. In a search of bills pending in the U.S. Congress this year and last year, none mention daylight saving.
< >
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Bybit Plays the Game of Expansion Step right up to Bybit’s latest offering – ByPick Season 2. Some folks might be scratching their heads about what's shifting in this free-to-play space, but here we are, watching a beast that’s a mix between a carnival game and a hedge fund playpen. No money exchanged, just knowledge on the line. That's right, we're diving into a...
Continue Reading
Cementing Long-Term Trust in Tartu Apartments When you're talking about real estate, especially with high groundwater levels, a solid foundation isn't just a metaphor—it's a lifeline. The 18-unit Saekoja 5 project in Tartu, Estonia, recognized this from the get-go, deciding to put PENETRON ADMIX SB through its paces for the elevator pits and foundation slab. Near the...
Continue Reading
PSE&G Climbs To Number One Spot: What's Changed? Public Service Electric & Gas (PSE&G), New Jersey's largest utility, just snagged the top spot for business electric customer satisfaction in the East, according to JD Power's latest study. This is an upgrade from their second place showing in 2025. But how did they leapfrog their competition to reach the pinnacle? The...
Continue Reading
Trouble at Endava: Leadership Shakeup and Financial Concerns So, here's the kicker—Endava's got itself into one mighty mess worth chewing over with your morning coffee. When your top brass drops like flies, and you're fumbling your financials, investors start sweating bullets. On October 28, 2026, Endava plc (NYSE: DAVA) confesses to some serious accounting missteps....
Continue Reading
TCL Electronics: Riding High on Strategic Moves Buckle up, because TCL Electronics has popped the hood and revealed quite the engine for growth. In the first three quarters of 2026, they cranked their adjusted profit up by a whopping 54.5%, hitting HK$2.24 billion. It's a hefty lift that would make any investor sit up and take notice. What's pushing this upswing? A...
Continue Reading
Longsys and Lexar: A Revolution in Storage Ah, the tech world—it's like a fast-moving express train you just can't afford to miss. Longsys and its sidekick Lexar are in the spotlight this time, and boy, they've got some head-turning announcements. At electronica 2026 in Munich, they're playing the storage game hard. From industrial-grade mSSD to automotive solutions,...
Continue Reading
Betting Big on Small Business If you've ever run a small business, you know it can feel like a hamster wheel—more customers usually mean more headaches. But here comes Worker.ai, stepping onto the scene with big promises and a fancy new acquisition. They've scooped up DeltaGen—a mover in real-time AI tech—and launched a platform to hand these overworked owners a...
Continue Reading
A Personal Mission Driving Business in Hollywood Dive deep into any community, and you'll often find stories that tug at the heartstrings—especially when they're about family. That's the case with Saudia Sital, a Broward County local who's just opened Always Best Care Senior Services in Hollywood, Florida. Her journey from personal caregiver to business owner isn't just...
Continue Reading
Holographics in Home Security: A Game Changer? Pittsburgh isn't exactly the Silicon Valley, but it seems like InventHelp's latest brainchild, the HOLOSECURE HUB, may bring a slice of futuristic tech to our living rooms. Crafted by a forward-thinking mind out of Indianapolis, this gizmo promises to blend the flashy, sci-fi allure of holographics with practical AI-driven...
Continue Reading
A New Chapter for CSTS and Sustainability Leadership Who would've thunk it? CSTS Enterprises, primarily known for its integrated media and sports ventures, is stepping into the sustainability arena as the Official Hospitality Partner for the Nobel Sustainability Trust Hong Kong Summit 2026. They're not just dipping a toe—they're diving headfirst into the pool, bringing...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding the Recent Developments in IMF Talks with Argentina The International Monetary Fund (IMF) is currently navigating a complicated landscape in its negotiations with Argentina, showcasing the ever-evolving nature of international finance and politics. Recently, Rodrigo Valdes, the IMF director for the Western Hemisphere, has officially assigned all negotiation...
Continue Reading
IO Biotech Unveils Breakthrough Pre-Clinical Data for Cancer Vaccines IO Biotech, a clinical-stage biopharmaceutical company listed on the Nasdaq under the ticker IOBT, is at the forefront of developing immune-modulatory, off-the-shelf therapeutic cancer vaccines. Recently, the company revealed exciting data highlighting its two promising candidates: IO112 and IO170, both...
Continue Reading
October Marijuana Stock Performance Overview The marijuana stock market has shown a diverse range of movements this October. Investors and enthusiasts remain eager to analyze these trends as companies navigate the ever-changing landscape of the cannabis industry. This article provides insights into the key movers within this sector, identifying both the top performers and...
Continue Reading
Compliance in the Fast Lane The compliance world just got a hefty upgrade with EQS Group's latest rollout: 'Q by EQS,' an AI-powered intelligence layer that's here to shake up the way compliance tasks are handled. It's integrated right into the heart of the EQS Compliance Cockpit, giving teams an edge by automating those pesky, time-sucking routines and guiding them...
Continue Reading
Olema Oncology to Present at Major Healthcare Event Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a dynamic clinical-stage biopharmaceutical company focused on developing targeted therapies for breast cancer and related conditions, is all set to present its innovative findings at the renowned J.P. Morgan Healthcare Conference. This key...
Continue Reading